Tag: Cancer: Misc.
Cutaneous AEs Linked to Immune Checkpoint Inhibitor Therapy
Cutaneous immune-related adverse events seen in 25 percent of cancer patients initiating ICI therapy with median onset time of 113 days
Socioeconomic Deprivation Linked to Worse Survival in Cancer Trials
Overall, progression-free, and cancer-specific survival worse for participants from areas with highest socioeconomic deprivation
Immediate Start of ART for HIV May Impact 10-Year Risk for Cancer
Deferral of antiretroviral therapy may lead to small increase in risk for AIDS-defining cancer
COVID-19 Impacting Caregivers of Children With Cancer
Changes to medical care, financial disruptions, and emotional distress reported
Globalization of Cancer Trials Tied to Lower Enrollment of Blacks
Significant inverse correlation identified between proportion of patients enrolled outside the U.S. and disparity score
Ambulatory Function Poorer for Older Cancer Survivors
Poorer ambulatory function associated with increased risks for mortality; significant associations seen for nine cancer types
Pediatric Oncology Services Disrupted During Pandemic
Newly diagnosed pediatric cancer cases decreased in 43 percent of centers; treatment abandonment increased in 34 percent
ASH Issues Guidance for Preventing, Treating VTE in Cancer
Use of thromboprophylaxis not recommended for ambulatory patients at low risk for VTE who are receiving chemotherapy
Mortality Gap Between Cancer, Heart Disease Narrowing for Women Younger Than 65
Age-adjusted mortality rates decreased for cancer and heart disease from 1999 to 2018, but increased for heart disease from 2010
Vascular Deaths Down for Diabetes Patients in the U.K.
Cancer is now the leading contributor to death among individuals with diabetes living in England
